M

Mazowieckie Centrum Badan Klinicznych | Grodzisk Mazowiecki, Poland

Research site
(Unclaimed)
Location
Daleka 32, Grodzisk Mazowiecki, Mazovia, Poland
Site insights

Top conditions

Chronic Progressive Multiple Sclerosis (1 trial)

Rheumatoid Arthritis (1 trial)

Arthritis (1 trial)

Osteoarthritis (1 trial)

Sclerosis (1 trial)

Top treatments

RTX-GRT7039
Ocrelizumab
R935788

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 3
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (O'HAND)

This study will evaluate the efficacy and safety of ocrelizumab ( Ocrevus®) compared with placebo in participants with primary progressive multiple s...

Enrolling
Multiple Sclerosis, Primary Progressive
Drug: Ocrelizumab
Drug: Placebo

A double-blind, randomized, placebo-controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated injections...

Active, not recruiting
Osteoarthritis
Drug: Placebo
Drug: RTX-GRT7039

Trial sponsors

G

Grünenthal (1 trial)

Rigel Pharmaceuticals logo

Rigel Pharmaceuticals (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems